Houda Alatassi

1.5k total citations
36 papers, 612 citations indexed

About

Houda Alatassi is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Houda Alatassi has authored 36 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Houda Alatassi's work include Phytochemicals and Medicinal Plants (6 papers), Renal cell carcinoma treatment (3 papers) and Renal and related cancers (3 papers). Houda Alatassi is often cited by papers focused on Phytochemicals and Medicinal Plants (6 papers), Renal cell carcinoma treatment (3 papers) and Renal and related cancers (3 papers). Houda Alatassi collaborates with scholars based in United States. Houda Alatassi's co-authors include Chendil Damodaran, Murali K. Ankem, Trinath P. Das, Suman Suman, Venkatesh Kolluru, Deeksha Pal, Mana Moghadamfalahi, Sunati Sahoo, Balaji Chandrasekaran and Suman Sirimulla and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and British Journal of Cancer.

In The Last Decade

Houda Alatassi

34 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Houda Alatassi United States 16 256 131 110 103 86 36 612
Jungmin Lee South Korea 13 215 0.8× 114 0.9× 93 0.8× 48 0.5× 50 0.6× 33 580
Michaela Lang Austria 16 341 1.3× 139 1.1× 139 1.3× 57 0.6× 103 1.2× 41 751
Yonghua Wang China 15 257 1.0× 70 0.5× 122 1.1× 38 0.4× 117 1.4× 48 569
Mahta Mazaheri Iran 19 195 0.8× 122 0.9× 36 0.3× 79 0.8× 122 1.4× 65 735
Chun‐Yi Chuang Taiwan 18 514 2.0× 160 1.2× 105 1.0× 37 0.4× 221 2.6× 56 963
Csaba Hegedűs Hungary 11 333 1.3× 118 0.9× 63 0.6× 26 0.3× 66 0.8× 20 612
Bing Zhong China 12 330 1.3× 68 0.5× 66 0.6× 25 0.2× 90 1.0× 25 614
Jiao Qu China 10 237 0.9× 120 0.9× 139 1.3× 44 0.4× 69 0.8× 19 557
Zhuogang Liu China 17 480 1.9× 145 1.1× 85 0.8× 37 0.4× 191 2.2× 61 831

Countries citing papers authored by Houda Alatassi

Since Specialization
Citations

This map shows the geographic impact of Houda Alatassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houda Alatassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houda Alatassi more than expected).

Fields of papers citing papers by Houda Alatassi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Houda Alatassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houda Alatassi. The network helps show where Houda Alatassi may publish in the future.

Co-authorship network of co-authors of Houda Alatassi

This figure shows the co-authorship network connecting the top 25 collaborators of Houda Alatassi. A scholar is included among the top collaborators of Houda Alatassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Houda Alatassi. Houda Alatassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tyagi, Ashish, Balaji Chandrasekaran, Venkatesh Kolluru, et al.. (2019). Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 37(7). 492–502. 30 indexed citations
2.
3.
Kolluru, Venkatesh, Balaji Chandrasekaran, Ashish Tyagi, et al.. (2018). miR-301a expression: Diagnostic and prognostic marker for prostate cancer. Urologic Oncology Seminars and Original Investigations. 36(11). 503.e9–503.e15. 20 indexed citations
4.
Pal, Deeksha, Balaji Chandrasekaran, Becca V. Baby, et al.. (2018). Abstract 3097: Chemo prevention effect of Withaferin A, a natural compound, on mouse models of colorectal carcinogenesis. Cancer Research. 78(13_Supplement). 3097–3097.
5.
Alatassi, Houda, et al.. (2017). Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro. International Journal of Pharmaceutics. 531(1). 118–133. 19 indexed citations
6.
Moselhy, Jim, Suman Suman, Mohammed Alghamdi, et al.. (2017). Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer. Neoplasia. 19(6). 451–459. 28 indexed citations
7.
Pal, Deeksha, Suman Suman, Venkatesh Kolluru, et al.. (2017). Inhibition of autophagy prevents cadmium-induced prostate carcinogenesis. British Journal of Cancer. 117(1). 56–64. 31 indexed citations
8.
Podoll, Mirna, et al.. (2017). Sarcomatous Component in Uterine Carcinosarcomas Correlates With Advanced Stage and Poorer Prognosis. International Journal of Gynecological Pathology. 37(1). 22–26.
9.
Alatassi, Houda, et al.. (2016). Nephroblastoma Arising from Primary Testicular Germ Cell Tumor: A Case Report and Literature Review. SHILAP Revista de lepidopterología. 2016. 1–4. 4 indexed citations
10.
Das, Trinath P., et al.. (2016). Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer. Cell Death and Disease. 7(2). e2111–e2111. 107 indexed citations
11.
Das, Trinath P., Suman Suman, Axel John, et al.. (2016). Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer. Cancer Letters. 377(2). 134–139. 33 indexed citations
12.
Damodaran, Chendil, Trinath P. Das, Axel John, et al.. (2016). miR-301a expression: A prognostic marker for prostate cancer. Urologic Oncology Seminars and Original Investigations. 34(8). 336.e13–336.e20. 25 indexed citations
13.
Pal, Deeksha, Venkatesh Kolluru, Balaji Chandrasekaran, et al.. (2016). Targeting aberrant expression of Notch‐1 in ALDH+ cancer stem cells in breast cancer. Molecular Carcinogenesis. 56(3). 1127–1136. 42 indexed citations
14.
Thomas, Shelia D., et al.. (2012). Tumor-associated primo vascular system is derived from xenograft, not host. Experimental and Molecular Pathology. 94(1). 84–90. 29 indexed citations
15.
Moore, Grace D., et al.. (2010). Presentation of Renal Cell Carcinoma as Cervical Polyp Metastasis. Journal of Lower Genital Tract Disease. 14(4). 387–389. 4 indexed citations
16.
Alatassi, Houda, et al.. (2010). Signet Ring Cell Carcinoma of the Gallbladder in a 22-Year-Old Man: A Case Report and Review of the Literature. International Journal of Surgical Pathology. 18(5). 358–362. 4 indexed citations
17.
Alatassi, Houda & Sunati Sahoo. (2009). Epithelioid angiomyolipoma of the liver with striking giant cell component: Fine‐needle aspiration biopsy findings of a rare neoplasm. Diagnostic Cytopathology. 37(3). 192–194. 15 indexed citations
18.
Alatassi, Houda, et al.. (2006). Rosai-Dorfman Disease of the Gastrointestinal Tract: Report of a Case and Review of the Literature. International Journal of Surgical Pathology. 14(1). 95–99. 24 indexed citations
19.
Alatassi, Houda, et al.. (2005). Breast Biopsy Marker Masquerading as a Mass Lesion. The Breast Journal. 11(6). 504–505. 1 indexed citations
20.
Alatassi, Houda, et al.. (2005). A 27-Year-Old Woman With an Incidental Renal Mass. Archives of Pathology & Laboratory Medicine. 129(8). e185–e186. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026